Response of chronic experimental cerebral vasospasm to methylprednisolone and dexamethasone
- 1 May 1984
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 60 (5) , 923-926
- https://doi.org/10.3171/jns.1984.60.5.0923
Abstract
The authors have previously demonstrated that high-dose methylprednisolone (30 mg/kg intravenously every 8 hours) prevents severe chronic vasospasm in dogs. In the present study, lesser doses of methylprednisolone (15 mg/kg intravenously every 8 hours) and dexamethasone (0.1 mg/kg intravenously every 8 hours), although better than no treatment at all, were significantly less effective than the higher dose of methylprednisolone. These data suggest that methylprednisolone can prevent chronic experimental vasospasm from occurring only when given in high doses (30 mg/kg).Keywords
This publication has 13 references indexed in Scilit:
- Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a “two-hemorrhage” canine modelJournal of Neurosurgery, 1983
- Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wallJournal of Neurosurgery, 1983
- The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar arteryJournal of Neurosurgery, 1981
- Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.Journal of Clinical Investigation, 1979
- Cerebral vasospasm and ultrastructural changes in cerebral arterial wallJournal of Neurosurgery, 1978
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- Cerebral Vasospasm with Ruptured Saccular Aneurysm — The Clinical ManifestationsNeurosurgery, 1977
- Cerebral vasospasm with ruptured saccular aneurysm???the clinical manifestationsNeurosurgery, 1977
- Cerebral arterial smooth muscle contraction by thromboxane A2.Stroke, 1977
- A Model for Experimental Cerebral Arterial SpasmStroke, 1972